Navigation Links
Biomarker test shows promise for melanoma diagnosis
Date:1/24/2011

Chapel Hill, NC A new study shows that a test of biomarkers for DNA methylation is technically feasible and could aid in earlier, more precise diagnosis of melanoma.

In a paper that appeared online last week in the journal Pigment Cell & Melanoma Research, a team of UNC researchers tested whether DNA methylation profiling could be accomplished on melanoma and mole tissues that had been preserved in fixatives for typical pathology examination after biopsy. They found that results on tissues prepared in this way were reliable and DNA methylation distinguished malignant melanomas from non-malignant moles.

Melanoma is one of the only forms of cancer that is still on the rise and is the most common form of cancer in young adults. The incidence of melanoma in women under age 30 has increased more than 50 percent since 1980.

"When melanoma is diagnosed early, the prognosis is good. However, once it spreads, it is very difficult to treat. Melanomas and moles can appear similar on the skin and under the microscope making diagnosis of some melanomas difficult. That's why we wanted to determine whether a test for DNA methylation is feasible as a tool for diagnosis," added Nancy Thomas, MD, PhD, professor of dermatology and a member of UNC Lineberger Comprehensive Cancer Center.

Kathleen Conway Dorsey, Ph.D, added, "We are very excited because, with this study, we have shown that this type of testing is feasible and that it has the potential to reliably distinguish between melanoma and benign skin lesions. Devising a molecular test that could aid in the early specific diagnosis of melanoma could have significant benefit for patients." Conway is assistant research professor of epidemiology at UNC's Gillings School of Global Public Health and a member of UNC Lineberger Comprehensive Cancer Center.

The team's research pinpointed sites on 22 genes that have significantly different methylation levels between melanomas and non-melanoma lesions, as well as 12 locations that are highly predictive of melanoma. According to Thomas, another goal of the team is to develop a DNA-methylation test for melanoma tumor DNA that is shed into the bloodstream and that can serve as a measure for disease activity.

"If this test can be developed, it opens the door to diagnose recurrence early and initiate treatment while tumors are more likely to respond to treatment. It would also give us another way to monitor patients for response to treatment and help us better optimize treatments for each patient," Thomas noted.


'/>"/>

Contact: Ellen de Graffenreid
edegraff@med.unc.edu
919-962-3405
University of North Carolina School of Medicine
Source:Eurekalert

Related medicine news :

1. Biomarker may be able to help predict risk of heart failure, cardiovascular death
2. Haptoglobin as an early serum biomarker of virus-induced type 1 diabetes in rats
3. Radiation pharmacogenomics identifies biomarkers that could personalize cancer treatment
4. Mayo researchers find biomarkers for personalizing radiation cancer treatment
5. c-Met may be a biomarker for metastatic hepatocellular carcinoma
6. Novel biomarker may predict response to new VEGF receptor inhibitor
7. Biomarkers May Aid in Early Diagnosis of Alzheimers
8. The cancer biomarker conundrum: Too many false discoveries
9. Biomarkers Could Spot Alzheimers Disease Early, Studies Suggest
10. Hydrophobic proteins: Potential biomarkers for colorectal cancer
11. A prognostic and predictive biomarker for nonsmall cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... education and high-level training standards for healthcare treatment providers who treat the full ... its Presidents Council. , The Presidents Council consists of the leading eating ...
(Date:1/23/2017)... ... 23, 2017 , ... Zachary Cattell, President of the Indiana ... industry expert at the 2017 Sector Summit hosted by Ivy Tech Community College ... Gerry Dick, will feature an employer and an association representative from five of ...
(Date:1/23/2017)... ... January 23, 2017 , ... Old School Labs™, makers ... Mr. Olympia Classic Physique bodybuilder Breon Ansley to its growing team of brand ambassadors. ... bodybuilder in 2012 and in less than a year was able to turn professional, ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Partnership (SNP) has launched online education programs and resources at seafoodnutrition.org/programs and ... nutritional benefits of a seafood-rich diet. These resources have been developed for ...
(Date:1/22/2017)... Boca Raton, FL (PRWEB) , ... January 22, 2017 , ... ... products to customers across the world, recently met with big-name retail buyers at the ... strong scientific evidence of efficacy and uses the utmost safety standards in all of ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Market Analysis & Trends - Technology, Route Of Administration, End User ... ... Market is poised to grow at a CAGR of around 7.8% ... This industry report analyzes the global markets for ...
(Date:1/20/2017)... Research and Markets has announced the addition of ... BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, ... 2024" report to their offering. ... The global clinical laboratory testing market is ... of innovative solutions on the grounds of maximum efficiency and minimum ...
(Date:1/20/2017)... 20, 2017  Ethicon Endo-Surgery, Inc. announced ... Products, Inc., a privately held medical device ... tools used in operating rooms worldwide. The ... advanced energy devices with Megadyne,s innovative portfolio ... forward in Ethicon,s goal to deliver the ...
Breaking Medicine Technology: